Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Gross margin79.3%0.0pp79.4%+0.2pp79.2%+1.0pp78.2%+0.6pp77.6%+1.9pp
Free cash flow margin18.1%-0.8pp18.8%+1.5pp17.3%+0.7pp16.6%-6.1pp22.7%-2.8pp
Efficiency
Asset turnover0.5×0.0×0.5×0.0×0.5×+0.1×0.4×0.0×0.4×0.0×
Inventory turnover1.1×0.0×1.1×0.0×1.1×-0.1×1.2×-0.1×1.4×-0.1×
Liquidity
Current ratio4.7×+0.2×4.5×-0.7×5.3×+2.9×2.4×0.0×2.4×0.0×
Quick ratio3.4×+0.1×3.3×-0.5×3.8×+1.9×1.9×-0.1×0.0×
Cash ratio1.3×0.0×1.3×-0.1×1.4×+0.4×+0.1×0.9×0.0×
Leverage
Debt-to-equity0.6×0.0×0.6×0.0×0.6×+0.1×0.5×0.0×0.4×-0.3×
Debt-to-assets0.3×0.0×0.3×0.0×0.3×+0.1×0.2×0.0×0.2×-0.1×
Per Share
Book value per share$15.98+3.9%$15.39-5.9%$16.36-1.9%$16.67-2.9%$17.16+2.0%
Valuation
Market capitalization$958.91M-14.5%$1.11B-3.8%$1.16B+1.6%$1.14B-0.9%$1.15B+32.2%
Enterprise value$1.23B+2.6%$1.37B-4.4%$1.44B+20.6%$1.19B-2.6%$1.22B+5.9%
Price / sales1.3×-0.3×1.5×-0.1×1.6×0.0×1.6×0.0×1.6×+0.4×
Price / book1.5×+0.1×1.6×0.0×1.6×+0.1×1.5×+0.1×1.4×+0.3×
EV / sales1.7×0.0×1.9×-0.1×+0.3×1.7×-0.1×1.7×+0.1×
Free cash flow yield13.8%-0.4pp12.3%+1.5pp10.7%+0.5pp10.3%-3.6pp13.9%-6.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Pacira BioSciences, Inc.'s profit margins?
Pacira BioSciences, Inc. (PCRX) runs a 79.3% gross margin and a 3.3% operating margin, with a 0.7% net margin.
Where do Pacira BioSciences, Inc.'s ratios come from?
Every ratio is computed from Pacira BioSciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.